A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/10/2011	WO2011059263A3 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/10/2011	WO2011051916A3 Stabilized protein formulations and use thereof
11/10/2011	WO2011047047A3 Composites containing polypeptides attached to polysaccharides and molecules
11/10/2011	WO2011008274A4 Reduced volume formulation of glatiramer acetate and methods of administration
11/10/2011	WO2010134970A8 Inhibition of prion protein propagation by receptor associated protein (rap). its derivatives, mimetics and synthetic peptides
11/10/2011	US20110277046 Hydrolases, nucleic acids encoding them and methods for making and using them
11/10/2011	US20110275982 Method for injecting drug into living body by electrospraying and device thereof
11/10/2011	US20110275886 Method to select animals with a high capacity of embryo production
11/10/2011	US20110275788 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275574 Method of inhibiting proliferation of hepatic stellate cells
11/10/2011	US20110275573 Tissue adhesive
11/10/2011	US20110275572 Nanocomposite Hyaluronic Acid-Clay Based Hydrogels
11/10/2011	US20110275571 Kv1.3 channel blocking substances for the treatment of diseases associated with intimal hyperplasia
11/10/2011	US20110275570 Process for obtaining a concentrate of von willebrand factor of a complex of factor viii/von willebrand factor and use of the same
11/10/2011	US20110275569 Proteases targeting agents
11/10/2011	US20110275568 Methods of enhancing functioning of the large intestine
11/10/2011	US20110275567 Aqueous composition containing follicle-stimulating hormone
11/10/2011	US20110275566 Methods of treating necrotizing enterocolitis using heparin binding epidermal growth factor (hb-egf)
11/10/2011	US20110275565 Biocompatible polysaccharide-based hydrogels
11/10/2011	US20110275564 Erythropoietin
11/10/2011	US20110275563 Use of CTGF as a Cardioprotectant
11/10/2011	US20110275562 Inhibition of gliadin peptides
11/10/2011	US20110275561 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
11/10/2011	US20110275560 Synthetic conjugates and uses thereof
11/10/2011	US20110275559 Long-Acting Y2 and/or Y4 Receptor Agonists
11/10/2011	US20110275558 Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders
11/10/2011	US20110275556 Treatment of atherosclerosis
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110275554 Compounds
11/10/2011	US20110275150 Compstatin analogs with improved activity
11/10/2011	US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids
11/10/2011	US20110275102 Activation of mutated rac-pk
11/10/2011	US20110275072 Egfr mutations
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274758 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
11/10/2011	US20110274756 Method and membrane for tissue regeneration
11/10/2011	US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
11/10/2011	US20110274747 C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)
11/10/2011	US20110274744 Process for preparing a surface coated by crosslinked polyelectrolyte multilayer films as a biomimetic reservoir for proteins
11/10/2011	US20110274741 Ingestible compositions and processes of preparation
11/10/2011	US20110274739 Methods for governing tissue growth
11/10/2011	US20110274738 Functionalized chemically inert polymers for coatings
11/10/2011	US20110274730 Biosurfactant composition produced by a new bacillus licheniforms strain, uses and products thereof
11/10/2011	US20110274725 Decomposable biocompatible hydrogels and system and method for using same
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274711 Hla-g polypeptides and pharmaceutical uses thereof
11/10/2011	US20110274708 Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
11/10/2011	US20110274705 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/10/2011	US20110274703 Detection and treatment of non-dermal fibrosis
11/10/2011	US20110274700 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274689 Compounds and methods to measure metabolic function and restore normal metabolic function
11/10/2011	US20110274688 Prevention of tumors with monoclonal antibodies against neu
11/10/2011	US20110274682 Methods for protease assisted protein delivery
11/10/2011	US20110274681 Human e3alpha ubiquitin ligase family
11/10/2011	US20110274680 Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases
11/10/2011	US20110274678 Beverage
11/10/2011	US20110274658 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
11/10/2011	US20110274657 Oxadiazole derivatives as s1p1 receptor antagonists
11/10/2011	US20110274656 Pharmaceutical composition for preventing or treating hepatitis c, comprising the roots extract of platycodon grandiflorum or platycodon grandiflorum saponin components
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274654 Triazoles as inhibitors of fatty acid synthase
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274652 Methods for Treating Hepatitis C Virus Infection
11/10/2011	US20110274651 Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition
11/10/2011	US20110274650 Compositions and methods of treating inflammatory and autoimmune diseases
11/10/2011	US20110274648 Hepatitis C Virus Inhibitors
11/10/2011	US20110274647 IL6R/IL6 Chimera for Therapy of Chemotherapy-Induced Peripheral Neuropathy
11/10/2011	US20110274646 Compounds and Combinations
11/10/2011	US20110274625 Liposomal Composition for Convection-Enhanced Delivery to the Central Nervous Centre
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274619 Brain tumor targeting peptides and methods
11/10/2011	US20110274618 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
11/10/2011	DE102010019336A1 Mittel zur Behandlung der Alzheimerschen Demenz Agents for the treatment of Alzheimer's dementia
11/10/2011	CA2835313A1 Gfi1b modulation and uses thereof
11/10/2011	CA2805267A1 Detection and treatment of fibrosis
11/10/2011	CA2798355A1 Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
11/10/2011	CA2798145A1 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
11/10/2011	CA2798139A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011	CA2797842A1 Immunogenic compositions and methods for treating neoplasia
11/10/2011	CA2795823A1 Methods of use of soluble cd24 for therapy of rheumatoid arthritis
11/10/2011	CA2795596A1 Agents for treating alzheimer's disease
11/09/2011	EP2385124A2 Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein
11/09/2011	EP2385123A1 MicroRNA molecules
11/09/2011	EP2385122A1 MicroRNA molecules
11/09/2011	EP2385121A1 Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents
11/09/2011	EP2385117A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP2385061A2 Neuritogenic peptides
11/09/2011	EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein
11/09/2011	EP2385056A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
11/09/2011	EP2384764A2 Compositions and methods for modulating hemostasis using variant forms of activated factor V
11/09/2011	EP2384763A1 A peptide ligand to impair cancer cell migration
11/09/2011	EP2384750A1 Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
11/09/2011	EP2384437A1 Mass spectrometry assay for congenital adrenal hyperplasia
11/09/2011	EP2384337A1 Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants
11/09/2011	EP2384336A1 A variant of mite allergen and uses thereof

1 ... 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 ... 3163